.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Merck
Cipla
Mallinckrodt
Argus Health
Teva
Dow
AstraZeneca
Julphar
Colorcon

Generated: June 24, 2017

DrugPatentWatch Database Preview

Methyl aminolevulinate hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for methyl aminolevulinate hydrochloride and what is the scope of methyl aminolevulinate hydrochloride patent protection?

Methyl aminolevulinate hydrochloride
is the generic ingredient in one branded drug marketed by Galderma Labs Lp and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four hundred and seventy-three drug master file entries for methyl aminolevulinate hydrochloride.

Summary for Generic Name: methyl aminolevulinate hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list473
Bulk Api Vendors: see list69
Clinical Trials: see list2,670
Patent Applications: see list1,199
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methyl aminolevulinate hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp
METVIXIA
methyl aminolevulinate hydrochloride
CREAM;TOPICAL021415-001Jul 27, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: methyl aminolevulinate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs Lp
METVIXIA
methyl aminolevulinate hydrochloride
CREAM;TOPICAL021415-001Jul 27, 20046,034,267► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Federal Trade Commission
Teva
Covington
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot